nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolmetin—PTGS2—glaucoma	0.494	1	CbGaD
Tolmetin—SLC22A6—Methazolamide—glaucoma	0.0867	0.556	CbGbCtD
Tolmetin—SLC22A6—Acetazolamide—glaucoma	0.0693	0.444	CbGbCtD
Tolmetin—Oedema—Metipranolol—glaucoma	0.00118	0.00504	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Dorzolamide—glaucoma	0.00115	0.00491	CcSEcCtD
Tolmetin—Oedema—Carteolol—glaucoma	0.00109	0.00467	CcSEcCtD
Tolmetin—Chest pain—Levobunolol—glaucoma	0.00108	0.0046	CcSEcCtD
Tolmetin—Drowsiness—Acetazolamide—glaucoma	0.00107	0.00459	CcSEcCtD
Tolmetin—Gastritis—Pilocarpine—glaucoma	0.00107	0.00456	CcSEcCtD
Tolmetin—Cardiac failure congestive—Clonidine—glaucoma	0.00106	0.00454	CcSEcCtD
Tolmetin—Thrombocytopenia—Diclofenamide—glaucoma	0.00105	0.00449	CcSEcCtD
Tolmetin—Somnolence—Metipranolol—glaucoma	0.00105	0.00448	CcSEcCtD
Tolmetin—Abdominal discomfort—Brinzolamide—glaucoma	0.00104	0.00444	CcSEcCtD
Tolmetin—Visual impairment—Apraclonidine—glaucoma	0.00104	0.00443	CcSEcCtD
Tolmetin—Dysuria—Dorzolamide—glaucoma	0.00103	0.00441	CcSEcCtD
Tolmetin—Drowsiness—Brimonidine—glaucoma	0.00103	0.0044	CcSEcCtD
Tolmetin—Dysuria—Travoprost—glaucoma	0.00103	0.00439	CcSEcCtD
Tolmetin—Haematuria—Acetazolamide—glaucoma	0.00102	0.00437	CcSEcCtD
Tolmetin—Ketorolac—PTGS2—glaucoma	0.00102	0.221	CrCbGaD
Tolmetin—Visual impairment—Bimatoprost—glaucoma	0.00101	0.0043	CcSEcCtD
Tolmetin—Agranulocytosis—Acetazolamide—glaucoma	0.001	0.00428	CcSEcCtD
Tolmetin—Chest pain—Latanoprost—glaucoma	0.000999	0.00427	CcSEcCtD
Tolmetin—Weight decreased—Dorzolamide—glaucoma	0.000998	0.00426	CcSEcCtD
Tolmetin—Anaphylactic shock—Methazolamide—glaucoma	0.000989	0.00422	CcSEcCtD
Tolmetin—Lymphadenopathy—Betaxolol—glaucoma	0.000983	0.0042	CcSEcCtD
Tolmetin—Bromfenac—PTGS2—glaucoma	0.000976	0.212	CrCbGaD
Tolmetin—Dysuria—Pilocarpine—glaucoma	0.000975	0.00417	CcSEcCtD
Tolmetin—Oedema—Latanoprost—glaucoma	0.000957	0.00409	CcSEcCtD
Tolmetin—Urinary tract infection—Dorzolamide—glaucoma	0.000956	0.00409	CcSEcCtD
Tolmetin—Somnolence—Diclofenamide—glaucoma	0.000955	0.00408	CcSEcCtD
Tolmetin—Urinary tract infection—Travoprost—glaucoma	0.000952	0.00407	CcSEcCtD
Tolmetin—Dyspepsia—Diclofenamide—glaucoma	0.000946	0.00404	CcSEcCtD
Tolmetin—Blood pressure increased—Timolol—glaucoma	0.000944	0.00403	CcSEcCtD
Tolmetin—Vascular purpura—Betaxolol—glaucoma	0.000938	0.00401	CcSEcCtD
Tolmetin—Epistaxis—Dorzolamide—glaucoma	0.000928	0.00396	CcSEcCtD
Tolmetin—Dyspepsia—Carbachol—glaucoma	0.000923	0.00394	CcSEcCtD
Tolmetin—Constipation—Diclofenamide—glaucoma	0.000919	0.00392	CcSEcCtD
Tolmetin—Agranulocytosis—Dorzolamide—glaucoma	0.000918	0.00392	CcSEcCtD
Tolmetin—Epistaxis—Brinzolamide—glaucoma	0.000912	0.0039	CcSEcCtD
Tolmetin—Erythema multiforme—Acetazolamide—glaucoma	0.000911	0.00389	CcSEcCtD
Tolmetin—Stomatitis—Pilocarpine—glaucoma	0.000906	0.00387	CcSEcCtD
Tolmetin—Urinary tract infection—Pilocarpine—glaucoma	0.000904	0.00386	CcSEcCtD
Tolmetin—Tinnitus—Acetazolamide—glaucoma	0.000899	0.00384	CcSEcCtD
Tolmetin—Visual impairment—Brimonidine—glaucoma	0.000891	0.00381	CcSEcCtD
Tolmetin—Blood urea increased—Timolol—glaucoma	0.000891	0.00381	CcSEcCtD
Tolmetin—Haematuria—Pilocarpine—glaucoma	0.000886	0.00379	CcSEcCtD
Tolmetin—Somnolence—Methazolamide—glaucoma	0.000879	0.00376	CcSEcCtD
Tolmetin—Epistaxis—Pilocarpine—glaucoma	0.000877	0.00375	CcSEcCtD
Tolmetin—Dyspepsia—Methazolamide—glaucoma	0.000871	0.00372	CcSEcCtD
Tolmetin—Purpura—Betaxolol—glaucoma	0.00087	0.00372	CcSEcCtD
Tolmetin—Visual impairment—Dorzolamide—glaucoma	0.000851	0.00364	CcSEcCtD
Tolmetin—Body temperature increased—Diclofenamide—glaucoma	0.000849	0.00363	CcSEcCtD
Tolmetin—Visual impairment—Travoprost—glaucoma	0.000848	0.00362	CcSEcCtD
Tolmetin—Asthenia—Metipranolol—glaucoma	0.000846	0.00361	CcSEcCtD
Tolmetin—Visual impairment—Brinzolamide—glaucoma	0.000837	0.00357	CcSEcCtD
Tolmetin—Erythema multiforme—Dorzolamide—glaucoma	0.000835	0.00357	CcSEcCtD
Tolmetin—Hepatitis—Pilocarpine—glaucoma	0.000835	0.00357	CcSEcCtD
Tolmetin—Lumiracoxib—PTGS2—glaucoma	0.00083	0.18	CrCbGaD
Tolmetin—Abdominal pain—Carbachol—glaucoma	0.000829	0.00354	CcSEcCtD
Tolmetin—Body temperature increased—Carbachol—glaucoma	0.000829	0.00354	CcSEcCtD
Tolmetin—Tinnitus—Dorzolamide—glaucoma	0.000824	0.00352	CcSEcCtD
Tolmetin—Urticaria—Levobunolol—glaucoma	0.00082	0.0035	CcSEcCtD
Tolmetin—Tinnitus—Travoprost—glaucoma	0.00082	0.0035	CcSEcCtD
Tolmetin—Tinnitus—Brinzolamide—glaucoma	0.00081	0.00346	CcSEcCtD
Tolmetin—Visual impairment—Pilocarpine—glaucoma	0.000804	0.00344	CcSEcCtD
Tolmetin—Chest pain—Apraclonidine—glaucoma	0.000798	0.00341	CcSEcCtD
Tolmetin—Urticaria—Methazolamide—glaucoma	0.000786	0.00336	CcSEcCtD
Tolmetin—Asthenia—Carteolol—glaucoma	0.000784	0.00335	CcSEcCtD
Tolmetin—Body temperature increased—Methazolamide—glaucoma	0.000782	0.00334	CcSEcCtD
Tolmetin—Dizziness—Metipranolol—glaucoma	0.00078	0.00333	CcSEcCtD
Tolmetin—Dysuria—Clonidine—glaucoma	0.000779	0.00333	CcSEcCtD
Tolmetin—Tinnitus—Pilocarpine—glaucoma	0.000778	0.00332	CcSEcCtD
Tolmetin—Chest pain—Bimatoprost—glaucoma	0.000774	0.00331	CcSEcCtD
Tolmetin—Asthenia—Diclofenamide—glaucoma	0.000771	0.00329	CcSEcCtD
Tolmetin—Oedema—Apraclonidine—glaucoma	0.000765	0.00327	CcSEcCtD
Tolmetin—Weight increased—Clonidine—glaucoma	0.000758	0.00324	CcSEcCtD
Tolmetin—Cardiac failure congestive—Timolol—glaucoma	0.000756	0.00323	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Betaxolol—glaucoma	0.000755	0.00323	CcSEcCtD
Tolmetin—Fenbufen—PTGS2—glaucoma	0.000755	0.164	CrCbGaD
Tolmetin—Flatulence—Brinzolamide—glaucoma	0.000745	0.00318	CcSEcCtD
Tolmetin—Drowsiness—Clonidine—glaucoma	0.000742	0.00317	CcSEcCtD
Tolmetin—Asthenia—Levobunolol—glaucoma	0.000741	0.00316	CcSEcCtD
Tolmetin—Headache—Metipranolol—glaucoma	0.000739	0.00316	CcSEcCtD
Tolmetin—Visual disturbance—Timolol—glaucoma	0.000723	0.00309	CcSEcCtD
Tolmetin—Dizziness—Carteolol—glaucoma	0.000723	0.00309	CcSEcCtD
Tolmetin—Urinary tract infection—Clonidine—glaucoma	0.000722	0.00308	CcSEcCtD
Tolmetin—Diarrhoea—Carbachol—glaucoma	0.000717	0.00306	CcSEcCtD
Tolmetin—Flatulence—Pilocarpine—glaucoma	0.000716	0.00306	CcSEcCtD
Tolmetin—Dizziness—Diclofenamide—glaucoma	0.00071	0.00303	CcSEcCtD
Tolmetin—Asthenia—Methazolamide—glaucoma	0.00071	0.00303	CcSEcCtD
Tolmetin—Diarrhoea—Levobunolol—glaucoma	0.000706	0.00302	CcSEcCtD
Tolmetin—Nausea—Metipranolol—glaucoma	0.000701	0.00299	CcSEcCtD
Tolmetin—Epistaxis—Clonidine—glaucoma	0.0007	0.00299	CcSEcCtD
Tolmetin—Dizziness—Carbachol—glaucoma	0.000693	0.00296	CcSEcCtD
Tolmetin—Chest pain—Brimonidine—glaucoma	0.000685	0.00293	CcSEcCtD
Tolmetin—Anaphylactic shock—Acetazolamide—glaucoma	0.000685	0.00292	CcSEcCtD
Tolmetin—Headache—Carteolol—glaucoma	0.000685	0.00292	CcSEcCtD
Tolmetin—Vomiting—Diclofenamide—glaucoma	0.000683	0.00292	CcSEcCtD
Tolmetin—Dizziness—Levobunolol—glaucoma	0.000683	0.00292	CcSEcCtD
Tolmetin—Somnolence—Apraclonidine—glaucoma	0.00068	0.00291	CcSEcCtD
Tolmetin—Dysuria—Betaxolol—glaucoma	0.000678	0.0029	CcSEcCtD
Tolmetin—Diarrhoea—Methazolamide—glaucoma	0.000677	0.00289	CcSEcCtD
Tolmetin—Headache—Diclofenamide—glaucoma	0.000673	0.00287	CcSEcCtD
Tolmetin—Thrombocytopenia—Acetazolamide—glaucoma	0.00067	0.00286	CcSEcCtD
Tolmetin—Vomiting—Carbachol—glaucoma	0.000667	0.00285	CcSEcCtD
Tolmetin—Hepatitis—Clonidine—glaucoma	0.000667	0.00285	CcSEcCtD
Tolmetin—Weight increased—Betaxolol—glaucoma	0.00066	0.00282	CcSEcCtD
Tolmetin—Somnolence—Bimatoprost—glaucoma	0.00066	0.00282	CcSEcCtD
Tolmetin—Oedema—Brimonidine—glaucoma	0.000657	0.00281	CcSEcCtD
Tolmetin—Headache—Carbachol—glaucoma	0.000657	0.00281	CcSEcCtD
Tolmetin—Weight decreased—Betaxolol—glaucoma	0.000656	0.0028	CcSEcCtD
Tolmetin—Chest pain—Dorzolamide—glaucoma	0.000655	0.0028	CcSEcCtD
Tolmetin—Constipation—Apraclonidine—glaucoma	0.000655	0.0028	CcSEcCtD
Tolmetin—Dyspepsia—Bimatoprost—glaucoma	0.000653	0.00279	CcSEcCtD
Tolmetin—Chest pain—Travoprost—glaucoma	0.000652	0.00278	CcSEcCtD
Tolmetin—Nausea—Carteolol—glaucoma	0.000649	0.00277	CcSEcCtD
Tolmetin—Headache—Levobunolol—glaucoma	0.000647	0.00276	CcSEcCtD
Tolmetin—Chest pain—Brinzolamide—glaucoma	0.000644	0.00275	CcSEcCtD
Tolmetin—Nausea—Diclofenamide—glaucoma	0.000638	0.00273	CcSEcCtD
Tolmetin—Dizziness—Latanoprost—glaucoma	0.000633	0.0027	CcSEcCtD
Tolmetin—Stomatitis—Betaxolol—glaucoma	0.00063	0.00269	CcSEcCtD
Tolmetin—Suprofen—PTGS2—glaucoma	0.000629	0.137	CrCbGaD
Tolmetin—Vomiting—Methazolamide—glaucoma	0.000629	0.00269	CcSEcCtD
Tolmetin—Anaphylactic shock—Dorzolamide—glaucoma	0.000628	0.00268	CcSEcCtD
Tolmetin—Oedema—Dorzolamide—glaucoma	0.000628	0.00268	CcSEcCtD
Tolmetin—Gastrointestinal pain—Apraclonidine—glaucoma	0.000626	0.00267	CcSEcCtD
Tolmetin—Oedema—Travoprost—glaucoma	0.000625	0.00267	CcSEcCtD
Tolmetin—Nausea—Carbachol—glaucoma	0.000623	0.00266	CcSEcCtD
Tolmetin—Tinnitus—Clonidine—glaucoma	0.000621	0.00265	CcSEcCtD
Tolmetin—Headache—Methazolamide—glaucoma	0.00062	0.00265	CcSEcCtD
Tolmetin—Chest pain—Pilocarpine—glaucoma	0.000619	0.00264	CcSEcCtD
Tolmetin—Nausea—Levobunolol—glaucoma	0.000613	0.00262	CcSEcCtD
Tolmetin—Epistaxis—Betaxolol—glaucoma	0.00061	0.0026	CcSEcCtD
Tolmetin—Somnolence—Acetazolamide—glaucoma	0.000609	0.0026	CcSEcCtD
Tolmetin—Abdominal pain—Apraclonidine—glaucoma	0.000605	0.00258	CcSEcCtD
Tolmetin—Agranulocytosis—Betaxolol—glaucoma	0.000603	0.00258	CcSEcCtD
Tolmetin—Dyspepsia—Acetazolamide—glaucoma	0.000603	0.00257	CcSEcCtD
Tolmetin—Headache—Latanoprost—glaucoma	0.0006	0.00256	CcSEcCtD
Tolmetin—Oedema—Pilocarpine—glaucoma	0.000593	0.00253	CcSEcCtD
Tolmetin—Nausea—Methazolamide—glaucoma	0.000588	0.00251	CcSEcCtD
Tolmetin—Somnolence—Brimonidine—glaucoma	0.000584	0.0025	CcSEcCtD
Tolmetin—Thrombocytopenia—Pilocarpine—glaucoma	0.000581	0.00248	CcSEcCtD
Tolmetin—Dyspepsia—Brimonidine—glaucoma	0.000578	0.00247	CcSEcCtD
Tolmetin—Visual impairment—Betaxolol—glaucoma	0.000559	0.00239	CcSEcCtD
Tolmetin—Somnolence—Dorzolamide—glaucoma	0.000558	0.00238	CcSEcCtD
Tolmetin—Dysuria—Timolol—glaucoma	0.000554	0.00237	CcSEcCtD
Tolmetin—Dyspepsia—Dorzolamide—glaucoma	0.000552	0.00236	CcSEcCtD
Tolmetin—Dyspepsia—Travoprost—glaucoma	0.00055	0.00235	CcSEcCtD
Tolmetin—Asthenia—Apraclonidine—glaucoma	0.000549	0.00235	CcSEcCtD
Tolmetin—Somnolence—Brinzolamide—glaucoma	0.000548	0.00234	CcSEcCtD
Tolmetin—Urticaria—Acetazolamide—glaucoma	0.000544	0.00232	CcSEcCtD
Tolmetin—Dyspepsia—Brinzolamide—glaucoma	0.000543	0.00232	CcSEcCtD
Tolmetin—Body temperature increased—Acetazolamide—glaucoma	0.000541	0.00231	CcSEcCtD
Tolmetin—Tinnitus—Betaxolol—glaucoma	0.000541	0.00231	CcSEcCtD
Tolmetin—Weight decreased—Timolol—glaucoma	0.000536	0.00229	CcSEcCtD
Tolmetin—Constipation—Travoprost—glaucoma	0.000534	0.00228	CcSEcCtD
Tolmetin—Asthenia—Bimatoprost—glaucoma	0.000532	0.00227	CcSEcCtD
Tolmetin—Somnolence—Pilocarpine—glaucoma	0.000527	0.00225	CcSEcCtD
Tolmetin—CXCL8—Cellular Senescence—TXN—glaucoma	0.000526	0.00472	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—NR3C1—glaucoma	0.000526	0.00472	CbGpPWpGaD
Tolmetin—Diarrhoea—Apraclonidine—glaucoma	0.000524	0.00224	CcSEcCtD
Tolmetin—Dyspepsia—Pilocarpine—glaucoma	0.000522	0.00223	CcSEcCtD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.000522	0.00468	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—IL1A—glaucoma	0.000519	0.00466	CbGpPWpGaD
Tolmetin—PTGS1—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000513	0.00461	CbGpPWpGaD
Tolmetin—Gastrointestinal pain—Dorzolamide—glaucoma	0.000513	0.00219	CcSEcCtD
Tolmetin—Gastrointestinal pain—Travoprost—glaucoma	0.000511	0.00218	CcSEcCtD
Tolmetin—Constipation—Pilocarpine—glaucoma	0.000507	0.00217	CcSEcCtD
Tolmetin—Dizziness—Apraclonidine—glaucoma	0.000506	0.00216	CcSEcCtD
Tolmetin—PTGS1—Overview of nanoparticle effects—PTGS2—glaucoma	0.000502	0.0045	CbGpPWpGaD
Tolmetin—SLC22A6—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000501	0.0045	CbGpPWpGaD
Tolmetin—Urticaria—Dorzolamide—glaucoma	0.000499	0.00213	CcSEcCtD
Tolmetin—Epistaxis—Timolol—glaucoma	0.000498	0.00213	CcSEcCtD
Tolmetin—Body temperature increased—Dorzolamide—glaucoma	0.000496	0.00212	CcSEcCtD
Tolmetin—Abdominal pain—Dorzolamide—glaucoma	0.000496	0.00212	CcSEcCtD
Tolmetin—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—glaucoma	0.000496	0.00445	CbGpPWpGaD
Tolmetin—Chest pain—Clonidine—glaucoma	0.000494	0.00211	CcSEcCtD
Tolmetin—Abdominal pain—Travoprost—glaucoma	0.000494	0.00211	CcSEcCtD
Tolmetin—Agranulocytosis—Timolol—glaucoma	0.000493	0.0021	CcSEcCtD
Tolmetin—Asthenia—Acetazolamide—glaucoma	0.000491	0.0021	CcSEcCtD
Tolmetin—Dizziness—Bimatoprost—glaucoma	0.000491	0.0021	CcSEcCtD
Tolmetin—Urticaria—Brinzolamide—glaucoma	0.00049	0.00209	CcSEcCtD
Tolmetin—Vomiting—Apraclonidine—glaucoma	0.000487	0.00208	CcSEcCtD
Tolmetin—MPO—IL23-mediated signaling events—TNF—glaucoma	0.000486	0.00436	CbGpPWpGaD
Tolmetin—Gastrointestinal pain—Pilocarpine—glaucoma	0.000485	0.00207	CcSEcCtD
Tolmetin—CXCL8—Bladder Cancer—VEGFA—glaucoma	0.000484	0.00434	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—MMP1—glaucoma	0.000483	0.00434	CbGpPWpGaD
Tolmetin—Headache—Apraclonidine—glaucoma	0.00048	0.00205	CcSEcCtD
Tolmetin—Oedema—Clonidine—glaucoma	0.000474	0.00202	CcSEcCtD
Tolmetin—Asthenia—Brimonidine—glaucoma	0.000471	0.00201	CcSEcCtD
Tolmetin—Body temperature increased—Pilocarpine—glaucoma	0.000469	0.002	CcSEcCtD
Tolmetin—Abdominal pain—Pilocarpine—glaucoma	0.000469	0.002	CcSEcCtD
Tolmetin—Diarrhoea—Acetazolamide—glaucoma	0.000468	0.002	CcSEcCtD
Tolmetin—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—glaucoma	0.000468	0.0042	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—RPTOR—glaucoma	0.000468	0.0042	CbGpPWpGaD
Tolmetin—Headache—Bimatoprost—glaucoma	0.000465	0.00199	CcSEcCtD
Tolmetin—Thrombocytopenia—Clonidine—glaucoma	0.000464	0.00198	CcSEcCtD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—NR3C1—glaucoma	0.000463	0.00416	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—FAS—glaucoma	0.000462	0.00415	CbGpPWpGaD
Tolmetin—Visual impairment—Timolol—glaucoma	0.000457	0.00195	CcSEcCtD
Tolmetin—CXCL8—Allograft Rejection—C3—glaucoma	0.000456	0.00409	CbGpPWpGaD
Tolmetin—Nausea—Apraclonidine—glaucoma	0.000455	0.00194	CcSEcCtD
Tolmetin—Dizziness—Acetazolamide—glaucoma	0.000453	0.00193	CcSEcCtD
Tolmetin—CXCL8—Spinal Cord Injury—NGFR—glaucoma	0.00045	0.00404	CbGpPWpGaD
Tolmetin—Asthenia—Dorzolamide—glaucoma	0.00045	0.00192	CcSEcCtD
Tolmetin—Asthenia—Travoprost—glaucoma	0.000448	0.00191	CcSEcCtD
Tolmetin—CXCL8—Metabolism of proteins—DHPS—glaucoma	0.000448	0.00402	CbGpPWpGaD
Tolmetin—Asthenia—Brinzolamide—glaucoma	0.000443	0.00189	CcSEcCtD
Tolmetin—Tinnitus—Timolol—glaucoma	0.000442	0.00189	CcSEcCtD
Tolmetin—CXCL8—GPCR ligand binding—OPN4—glaucoma	0.000441	0.00396	CbGpPWpGaD
Tolmetin—Nausea—Bimatoprost—glaucoma	0.000441	0.00188	CcSEcCtD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000436	0.00391	CbGpPWpGaD
Tolmetin—Vomiting—Acetazolamide—glaucoma	0.000435	0.00186	CcSEcCtD
Tolmetin—Dizziness—Brimonidine—glaucoma	0.000435	0.00186	CcSEcCtD
Tolmetin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—CDKN2B—glaucoma	0.000433	0.00389	CbGpPWpGaD
Tolmetin—Chest pain—Betaxolol—glaucoma	0.00043	0.00184	CcSEcCtD
Tolmetin—Diarrhoea—Dorzolamide—glaucoma	0.000429	0.00183	CcSEcCtD
Tolmetin—Headache—Acetazolamide—glaucoma	0.000429	0.00183	CcSEcCtD
Tolmetin—CXCL8—ATF-2 transcription factor network—MMP2—glaucoma	0.000429	0.00385	CbGpPWpGaD
Tolmetin—Diarrhoea—Travoprost—glaucoma	0.000428	0.00183	CcSEcCtD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—MMP1—glaucoma	0.000426	0.00382	CbGpPWpGaD
Tolmetin—Asthenia—Pilocarpine—glaucoma	0.000425	0.00182	CcSEcCtD
Tolmetin—Diarrhoea—Brinzolamide—glaucoma	0.000422	0.0018	CcSEcCtD
Tolmetin—Somnolence—Clonidine—glaucoma	0.000421	0.0018	CcSEcCtD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.00042	0.00377	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—TXN—glaucoma	0.00042	0.00377	CbGpPWpGaD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—glaucoma	0.000419	0.00376	CbGpPWpGaD
Tolmetin—PTGS1—Eicosanoid Synthesis—PTGS2—glaucoma	0.000416	0.00373	CbGpPWpGaD
Tolmetin—Dizziness—Dorzolamide—glaucoma	0.000415	0.00177	CcSEcCtD
Tolmetin—Dizziness—Travoprost—glaucoma	0.000413	0.00176	CcSEcCtD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—IL1A—glaucoma	0.000413	0.00371	CbGpPWpGaD
Tolmetin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—IL1A—glaucoma	0.000413	0.00371	CbGpPWpGaD
Tolmetin—Oedema—Betaxolol—glaucoma	0.000412	0.00176	CcSEcCtD
Tolmetin—Headache—Brimonidine—glaucoma	0.000412	0.00176	CcSEcCtD
Tolmetin—Dizziness—Brinzolamide—glaucoma	0.000408	0.00174	CcSEcCtD
Tolmetin—PTGS2—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000407	0.00366	CbGpPWpGaD
Tolmetin—Nausea—Acetazolamide—glaucoma	0.000407	0.00174	CcSEcCtD
Tolmetin—Diarrhoea—Pilocarpine—glaucoma	0.000406	0.00173	CcSEcCtD
Tolmetin—Constipation—Clonidine—glaucoma	0.000405	0.00173	CcSEcCtD
Tolmetin—Thrombocytopenia—Betaxolol—glaucoma	0.000404	0.00172	CcSEcCtD
Tolmetin—CXCL8—LPA receptor mediated events—MMP2—glaucoma	0.000402	0.0036	CbGpPWpGaD
Tolmetin—Indomethacin—PTGS2—glaucoma	0.0004	0.0868	CrCbGaD
Tolmetin—MPO—C-MYB transcription factor network—CDKN2A—glaucoma	0.000399	0.00358	CbGpPWpGaD
Tolmetin—Vomiting—Dorzolamide—glaucoma	0.000399	0.0017	CcSEcCtD
Tolmetin—CXCL8—Cellular responses to stress—TXN—glaucoma	0.000398	0.00357	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—PTGFR—glaucoma	0.000397	0.00357	CbGpPWpGaD
Tolmetin—Headache—Dorzolamide—glaucoma	0.000393	0.00168	CcSEcCtD
Tolmetin—Vomiting—Brinzolamide—glaucoma	0.000392	0.00168	CcSEcCtD
Tolmetin—Dizziness—Pilocarpine—glaucoma	0.000392	0.00167	CcSEcCtD
Tolmetin—CXCL8—Spinal Cord Injury—BDNF—glaucoma	0.000392	0.00352	CbGpPWpGaD
Tolmetin—Headache—Travoprost—glaucoma	0.000391	0.00167	CcSEcCtD
Tolmetin—Nausea—Brimonidine—glaucoma	0.00039	0.00167	CcSEcCtD
Tolmetin—Gastrointestinal pain—Clonidine—glaucoma	0.000387	0.00165	CcSEcCtD
Tolmetin—Headache—Brinzolamide—glaucoma	0.000387	0.00165	CcSEcCtD
Tolmetin—TDO2—Metabolism—CA1—glaucoma	0.000382	0.00343	CbGpPWpGaD
Tolmetin—Vomiting—Pilocarpine—glaucoma	0.000377	0.00161	CcSEcCtD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—PEX19—glaucoma	0.000377	0.00338	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—IL1A—glaucoma	0.000376	0.00338	CbGpPWpGaD
Tolmetin—Urticaria—Clonidine—glaucoma	0.000376	0.00161	CcSEcCtD
Tolmetin—MPO—Vitamin B12 Metabolism—TNF—glaucoma	0.000376	0.00337	CbGpPWpGaD
Tolmetin—Abdominal pain—Clonidine—glaucoma	0.000374	0.0016	CcSEcCtD
Tolmetin—Body temperature increased—Clonidine—glaucoma	0.000374	0.0016	CcSEcCtD
Tolmetin—MPO—C-MYB transcription factor network—PTGS2—glaucoma	0.000373	0.00335	CbGpPWpGaD
Tolmetin—Nausea—Dorzolamide—glaucoma	0.000373	0.00159	CcSEcCtD
Tolmetin—PTGS2—Spinal Cord Injury—C1QB—glaucoma	0.000372	0.00334	CbGpPWpGaD
Tolmetin—Headache—Pilocarpine—glaucoma	0.000371	0.00159	CcSEcCtD
Tolmetin—Nausea—Travoprost—glaucoma	0.000371	0.00159	CcSEcCtD
Tolmetin—TDO2—Metabolism—CTSA—glaucoma	0.00037	0.00332	CbGpPWpGaD
Tolmetin—Nausea—Brinzolamide—glaucoma	0.000366	0.00157	CcSEcCtD
Tolmetin—CXCL8—Bladder Cancer—TP53—glaucoma	0.000366	0.00328	CbGpPWpGaD
Tolmetin—Dyspepsia—Betaxolol—glaucoma	0.000363	0.00155	CcSEcCtD
Tolmetin—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—glaucoma	0.00036	0.00323	CbGpPWpGaD
Tolmetin—PTGS1—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.00036	0.00323	CbGpPWpGaD
Tolmetin—MPO—Selenium Micronutrient Network—PTGS2—glaucoma	0.00036	0.00323	CbGpPWpGaD
Tolmetin—MPO—C-MYB transcription factor network—CDKN1B—glaucoma	0.000354	0.00317	CbGpPWpGaD
Tolmetin—Constipation—Betaxolol—glaucoma	0.000353	0.00151	CcSEcCtD
Tolmetin—Nausea—Pilocarpine—glaucoma	0.000352	0.0015	CcSEcCtD
Tolmetin—Chest pain—Timolol—glaucoma	0.000351	0.0015	CcSEcCtD
Tolmetin—TDO2—Metabolism—CA2—glaucoma	0.000349	0.00313	CbGpPWpGaD
Tolmetin—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—glaucoma	0.000348	0.00312	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—CDKN2A—glaucoma	0.000343	0.00307	CbGpPWpGaD
Tolmetin—Asthenia—Clonidine—glaucoma	0.00034	0.00145	CcSEcCtD
Tolmetin—PTGS1—Overview of nanoparticle effects—TNF—glaucoma	0.000339	0.00304	CbGpPWpGaD
Tolmetin—Anaphylactic shock—Timolol—glaucoma	0.000337	0.00144	CcSEcCtD
Tolmetin—Oedema—Timolol—glaucoma	0.000337	0.00144	CcSEcCtD
Tolmetin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—glaucoma	0.000336	0.00301	CbGpPWpGaD
Tolmetin—SLC22A6—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000334	0.003	CbGpPWpGaD
Tolmetin—Urticaria—Betaxolol—glaucoma	0.000328	0.0014	CcSEcCtD
Tolmetin—PTGS1—Selenium Micronutrient Network—ABCA1—glaucoma	0.000327	0.00293	CbGpPWpGaD
Tolmetin—Body temperature increased—Betaxolol—glaucoma	0.000326	0.00139	CcSEcCtD
Tolmetin—Diarrhoea—Clonidine—glaucoma	0.000324	0.00138	CcSEcCtD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—FN1—glaucoma	0.000319	0.00286	CbGpPWpGaD
Tolmetin—PTGS2—S1P1 pathway—VEGFA—glaucoma	0.000314	0.00282	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000313	0.00281	CbGpPWpGaD
Tolmetin—Dizziness—Clonidine—glaucoma	0.000313	0.00134	CcSEcCtD
Tolmetin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—glaucoma	0.000308	0.00276	CbGpPWpGaD
Tolmetin—MPO—Folate Metabolism—TNF—glaucoma	0.000306	0.00274	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—CDKN1B—glaucoma	0.000303	0.00272	CbGpPWpGaD
Tolmetin—CXCL8—LPA receptor mediated events—MMP9—glaucoma	0.000302	0.00271	CbGpPWpGaD
Tolmetin—Vomiting—Clonidine—glaucoma	0.000301	0.00129	CcSEcCtD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000301	0.0027	CbGpPWpGaD
Tolmetin—Somnolence—Timolol—glaucoma	0.000299	0.00128	CcSEcCtD
Tolmetin—Headache—Clonidine—glaucoma	0.000297	0.00127	CcSEcCtD
Tolmetin—Dyspepsia—Timolol—glaucoma	0.000296	0.00127	CcSEcCtD
Tolmetin—Asthenia—Betaxolol—glaucoma	0.000296	0.00126	CcSEcCtD
Tolmetin—PTGS1—Selenium Micronutrient Network—SOD1—glaucoma	0.000291	0.00261	CbGpPWpGaD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—glaucoma	0.000283	0.00254	CbGpPWpGaD
Tolmetin—Diarrhoea—Betaxolol—glaucoma	0.000282	0.0012	CcSEcCtD
Tolmetin—CXCL8—Corticotropin-releasing hormone—NOS3—glaucoma	0.000281	0.00253	CbGpPWpGaD
Tolmetin—Nausea—Clonidine—glaucoma	0.000281	0.0012	CcSEcCtD
Tolmetin—CXCL8—AP-1 transcription factor network—MMP9—glaucoma	0.000281	0.00252	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—CTSA—glaucoma	0.000279	0.00251	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—NGF—glaucoma	0.000278	0.0025	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.000277	0.00248	CbGpPWpGaD
Tolmetin—Gastrointestinal pain—Timolol—glaucoma	0.000275	0.00118	CcSEcCtD
Tolmetin—CXCL8—Cellular Senescence—CDKN2B—glaucoma	0.000274	0.00246	CbGpPWpGaD
Tolmetin—Dizziness—Betaxolol—glaucoma	0.000273	0.00116	CcSEcCtD
Tolmetin—MPO—Folate Metabolism—TP53—glaucoma	0.000269	0.00242	CbGpPWpGaD
Tolmetin—PTGS2—Overview of nanoparticle effects—TNF—glaucoma	0.000269	0.00241	CbGpPWpGaD
Tolmetin—Urticaria—Timolol—glaucoma	0.000268	0.00114	CcSEcCtD
Tolmetin—Body temperature increased—Timolol—glaucoma	0.000266	0.00114	CcSEcCtD
Tolmetin—Abdominal pain—Timolol—glaucoma	0.000266	0.00114	CcSEcCtD
Tolmetin—Vomiting—Betaxolol—glaucoma	0.000262	0.00112	CcSEcCtD
Tolmetin—CXCL8—Cellular Senescence—IL1A—glaucoma	0.000261	0.00235	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—ABCA1—glaucoma	0.000259	0.00233	CbGpPWpGaD
Tolmetin—CXCL8—Peptide ligand-binding receptors—EDN1—glaucoma	0.000259	0.00232	CbGpPWpGaD
Tolmetin—Headache—Betaxolol—glaucoma	0.000258	0.0011	CcSEcCtD
Tolmetin—CXCL8—Metabolism of proteins—ACE2—glaucoma	0.000257	0.00231	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000255	0.00228	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—glaucoma	0.000252	0.00227	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—OPN4—glaucoma	0.000249	0.00224	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—CDKN2A—glaucoma	0.000248	0.00222	CbGpPWpGaD
Tolmetin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—CDKN2A—glaucoma	0.000248	0.00222	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—TXN—glaucoma	0.000246	0.00221	CbGpPWpGaD
Tolmetin—Nausea—Betaxolol—glaucoma	0.000245	0.00105	CcSEcCtD
Tolmetin—SLC22A6—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000245	0.0022	CbGpPWpGaD
Tolmetin—MPO—Selenium Micronutrient Network—TNF—glaucoma	0.000243	0.00218	CbGpPWpGaD
Tolmetin—Asthenia—Timolol—glaucoma	0.000242	0.00103	CcSEcCtD
Tolmetin—PTGS1—Biological oxidations—GSTT1—glaucoma	0.00024	0.00215	CbGpPWpGaD
Tolmetin—PTGS1—Arachidonic acid metabolism—PTGS2—glaucoma	0.000231	0.00208	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—SOD1—glaucoma	0.000231	0.00207	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—MTHFR—glaucoma	0.000231	0.00207	CbGpPWpGaD
Tolmetin—Diarrhoea—Timolol—glaucoma	0.00023	0.000984	CcSEcCtD
Tolmetin—CXCL8—Allograft Rejection—VEGFA—glaucoma	0.000229	0.00206	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—OPN4—glaucoma	0.000226	0.00203	CbGpPWpGaD
Tolmetin—CXCL8—Peptide ligand-binding receptors—C3—glaucoma	0.000226	0.00203	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—PTGFR—glaucoma	0.000224	0.00201	CbGpPWpGaD
Tolmetin—Dizziness—Timolol—glaucoma	0.000223	0.000951	CcSEcCtD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—CDKN1B—glaucoma	0.000219	0.00197	CbGpPWpGaD
Tolmetin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—CDKN1B—glaucoma	0.000219	0.00197	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—SOD1—glaucoma	0.000219	0.00197	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—GSTM1—glaucoma	0.000215	0.00193	CbGpPWpGaD
Tolmetin—Vomiting—Timolol—glaucoma	0.000214	0.000915	CcSEcCtD
Tolmetin—Headache—Timolol—glaucoma	0.000211	0.000901	CcSEcCtD
Tolmetin—CXCL8—Spinal Cord Injury—PTGS2—glaucoma	0.000211	0.00189	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—CDKN2B—glaucoma	0.000207	0.00186	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PTGFR—glaucoma	0.000204	0.00183	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—SMO—glaucoma	0.0002	0.0018	CbGpPWpGaD
Tolmetin—Nausea—Timolol—glaucoma	0.0002	0.000855	CcSEcCtD
Tolmetin—CXCL8—Spinal Cord Injury—CDKN1B—glaucoma	0.0002	0.00179	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—IL1A—glaucoma	0.000198	0.00177	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—NGFR—glaucoma	0.000197	0.00177	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—TNF—glaucoma	0.000196	0.00176	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—LRP12—glaucoma	0.000193	0.00173	CbGpPWpGaD
Tolmetin—PTGS1—Biological oxidations—CYP1B1—glaucoma	0.000191	0.00171	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—GSTT1—glaucoma	0.000191	0.00171	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—TP53—glaucoma	0.000191	0.00171	CbGpPWpGaD
Tolmetin—CXCL8—G alpha (i) signalling events—C3—glaucoma	0.000191	0.00171	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	0.000186	0.00167	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—MMP9—glaucoma	0.000185	0.00166	CbGpPWpGaD
Tolmetin—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—glaucoma	0.000185	0.00166	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—MTHFR—glaucoma	0.000183	0.00164	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000178	0.0016	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000173	0.00156	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—BDNF—glaucoma	0.000172	0.00154	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000171	0.00154	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.00017	0.00152	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—NARFL—glaucoma	0.000168	0.00151	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CA5A—glaucoma	0.000168	0.00151	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—TP53—glaucoma	0.000168	0.00151	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IL1A—glaucoma	0.000165	0.00148	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—TNF—glaucoma	0.00016	0.00144	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—CDKN2A—glaucoma	0.000157	0.00141	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	0.000155	0.00139	CbGpPWpGaD
Tolmetin—PTGS1—Biological oxidations—GSTM1—glaucoma	0.000153	0.00137	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—ABCA1—glaucoma	0.000152	0.00136	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—CYP1B1—glaucoma	0.000152	0.00136	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000152	0.00136	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—PTGS2—glaucoma	0.000147	0.00132	CbGpPWpGaD
Tolmetin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—glaucoma	0.000145	0.0013	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—TNF—glaucoma	0.000142	0.00128	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000142	0.00127	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—CDKN1B—glaucoma	0.000139	0.00125	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—TP53—glaucoma	0.000138	0.00124	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—PAX6—glaucoma	0.000137	0.00123	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—OPN4—glaucoma	0.000134	0.0012	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CA5A—glaucoma	0.000133	0.0012	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—NARFL—glaucoma	0.000133	0.0012	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.000133	0.00119	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—TNF—glaucoma	0.000133	0.00119	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—EDN1—glaucoma	0.000132	0.00119	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—CDKN2A—glaucoma	0.00013	0.00116	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000128	0.00114	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—TP53—glaucoma	0.000126	0.00113	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—TNF—glaucoma	0.000125	0.00112	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HEYL—glaucoma	0.000124	0.00112	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000124	0.00112	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—glaucoma	0.000124	0.00111	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—GSTM1—glaucoma	0.000121	0.00109	CbGpPWpGaD
Tolmetin—PTGS2—Disease—LRP12—glaucoma	0.000121	0.00108	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PTGFR—glaucoma	0.00012	0.00108	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—CDKN2A—glaucoma	0.000118	0.00106	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000118	0.00105	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000117	0.00105	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—C3—glaucoma	0.000115	0.00104	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—CDKN1B—glaucoma	0.000115	0.00103	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—TNF—glaucoma	0.000114	0.00102	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—MTHFR—glaucoma	0.000107	0.000964	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—CDKN1B—glaucoma	0.000105	0.000941	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—SMO—glaucoma	0.000103	0.000923	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—APOE—glaucoma	0.0001	0.000897	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	9.99e-05	0.000897	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—TNF—glaucoma	9.94e-05	0.000892	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—CAV1—glaucoma	9.9e-05	0.000889	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—RPTOR—glaucoma	9.42e-05	0.000846	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NCK2—glaucoma	9.13e-05	0.000819	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—CDKN1B—glaucoma	8.75e-05	0.000785	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—VEGFA—glaucoma	8.72e-05	0.000783	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—TP53—glaucoma	8.72e-05	0.000783	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	8.55e-05	0.000767	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CA1—glaucoma	8.21e-05	0.000736	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—MMP9—glaucoma	8.1e-05	0.000727	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CTSA—glaucoma	7.95e-05	0.000713	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—TNF—glaucoma	7.89e-05	0.000708	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—MMP1—glaucoma	7.81e-05	0.000701	CbGpPWpGaD
Tolmetin—PTGS2—Disease—FGFR1OP—glaucoma	7.78e-05	0.000698	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HEYL—glaucoma	7.78e-05	0.000698	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HDAC9—glaucoma	7.76e-05	0.000696	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CA2—glaucoma	7.51e-05	0.000674	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—NOS3—glaucoma	7.49e-05	0.000672	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—EDN1—glaucoma	7.46e-05	0.00067	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	7.34e-05	0.000658	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	7.34e-05	0.000658	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PTGS2—glaucoma	6.85e-05	0.000615	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—EDN1—glaucoma	6.78e-05	0.000608	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—TP53—glaucoma	6.59e-05	0.000592	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—C3—glaucoma	6.52e-05	0.000585	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CA1—glaucoma	6.51e-05	0.000585	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CTSA—glaucoma	6.31e-05	0.000566	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TNF—glaucoma	6.24e-05	0.00056	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SMO—glaucoma	6.07e-05	0.000545	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—MMP2—glaucoma	6.04e-05	0.000542	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CA2—glaucoma	5.96e-05	0.000535	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	5.95e-05	0.000534	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—C3—glaucoma	5.92e-05	0.000531	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	5.82e-05	0.000523	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	5.82e-05	0.000523	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NTRK2—glaucoma	5.55e-05	0.000498	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TP53—glaucoma	5.5e-05	0.000494	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—TXN—glaucoma	5.29e-05	0.000475	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	4.95e-05	0.000444	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HDAC9—glaucoma	4.85e-05	0.000436	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—APOE—glaucoma	4.83e-05	0.000433	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	4.78e-05	0.000429	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NGFR—glaucoma	4.77e-05	0.000428	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NTRK1—glaucoma	4.53e-05	0.000406	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	4.24e-05	0.000381	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—TXN—glaucoma	4.2e-05	0.000377	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CDKN2B—glaucoma	4.17e-05	0.000374	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GSTT1—glaucoma	4.1e-05	0.000368	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—EDN1—glaucoma	4e-05	0.000359	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.83e-05	0.000344	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3.8e-05	0.000341	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	3.74e-05	0.000336	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NGF—glaucoma	3.68e-05	0.00033	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—C3—glaucoma	3.5e-05	0.000314	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	3.31e-05	0.000297	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ABCA1—glaucoma	3.27e-05	0.000293	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CYP1B1—glaucoma	3.27e-05	0.000293	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—APOE—glaucoma	3.26e-05	0.000292	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GSTT1—glaucoma	3.25e-05	0.000292	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CAV1—glaucoma	3.23e-05	0.00029	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—FN1—glaucoma	3.07e-05	0.000276	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—BAD—glaucoma	3.03e-05	0.000272	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GSTM1—glaucoma	2.61e-05	0.000234	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CDKN2B—glaucoma	2.61e-05	0.000234	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ABCA1—glaucoma	2.59e-05	0.000233	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CYP1B1—glaucoma	2.59e-05	0.000233	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NOS3—glaucoma	2.44e-05	0.000219	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—MTHFR—glaucoma	2.31e-05	0.000207	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MTHFR—glaucoma	2.19e-05	0.000196	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—APOE—glaucoma	2.15e-05	0.000193	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CAV1—glaucoma	2.13e-05	0.000191	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CDKN1B—glaucoma	2.11e-05	0.00019	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GSTM1—glaucoma	2.07e-05	0.000186	CbGpPWpGaD
Tolmetin—PTGS2—Disease—APOE—glaucoma	2.04e-05	0.000183	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CAV1—glaucoma	2.02e-05	0.000181	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MMP9—glaucoma	1.96e-05	0.000176	CbGpPWpGaD
Tolmetin—PTGS2—Disease—BAD—glaucoma	1.9e-05	0.00017	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—MTHFR—glaucoma	1.83e-05	0.000164	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—VEGFA—glaucoma	1.76e-05	0.000158	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—APOE—glaucoma	1.71e-05	0.000153	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CAV1—glaucoma	1.69e-05	0.000152	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—NOS3—glaucoma	1.61e-05	0.000144	CbGpPWpGaD
Tolmetin—PTGS2—Disease—NOS3—glaucoma	1.53e-05	0.000137	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PTGS2—glaucoma	1.47e-05	0.000132	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TP53—glaucoma	1.33e-05	0.000119	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CDKN1B—glaucoma	1.32e-05	0.000119	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—NOS3—glaucoma	1.28e-05	0.000115	CbGpPWpGaD
